1 Trademark Results found for "NOSCIRA"

Also try searching for:

NOSCIRA*

NOSC*

*IRA

NO*RA

Mark	Details	Status	Class/Description
	NOSCIRA NOSCIRA S.A. 1415500 22 Oct 2008	ABANDONED SECTION 40(3) on 14 Nov 2012	1) Chemicals, reagents, compounds, and solvents for scientific and med... Class 001 Class 001 Chemical Products 1) Chemicals, reagents, compounds, and solvents for scientific and medical research; Pharmaceutical and veterinary preparations for the treatment of the nervous system diseases and conditions, namely cognitive disorders namely pre-senile dementia, senile dementia, cerebrovascular dementia, AIDS associated dementia, frontotemporal dementia, mild cognitive impairment and attention deficit disorder, neurogenerative dementing disease, namely Alzheimer's disease, attention deficit symptoms associated with Alzheimers disease, diffuse Lewy body type Alzheimers disease, memory loss, Parkinson's disease, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex polyglutamine disease, Hungtington's disease, tauopathies as Pick's disease, multiple system atrophy (MSA), frontotemporal lobular degeneration, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis, multiple sclerosis, Friedreichs ataxia, tardive dyskynesia, states of muscular dystrophy, Hereditary Cerebral Hemmorhage with Amyloidosis of the Dutch-Type, cerebral bleeding namely due to solitary cerebral amyloid angiopathy, ß-amyloid angiopathy and systemic amyloidosis and condition, neurotraumatic disease namely stroke, acute stroke, promotion of functional recovery post stroke, ischaemia, anxiety, epilepsy, brain injury, traumatic brain injury, brain diseases, head trauma, encephalitis, neural damage, crush injury, reperfusion injury, spinal cord injury, optic nerve injury, namely that caused by glaucoma, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, chronic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease, prion diseases as spongiform encephalopathy, Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinher disease, drug and alcohol addiction and mood disorders, namely depression, psychoses, schizophrenia and bipolar disorders, conditions associated with diabetes, namely non-insulin dependent diabetes mellitus and diabetes type II; Natural and synthetic bioactive preparations for application in the fields of human or animal medicine, namely pharmaceutical and veterinary preparations for the treatment of the nervous system diseases and conditions, namely cognitive disorders, namely pre-senile dementia, senile dementia, cerebrovascular dementia, AIDS associated dementia, frontotemporal dementia, mild cognitive impairment and attention deficit disorder, neurogenerative dementing disease, namely Alzheimer's disease, attention deficit symptoms associated with Alzheimers disease, diffuse Lewy body type Alzheimers disease, memory loss, Parkinson's disease, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex polyglutamine disease, Hungtington's disease, tauopathies as Pick's disease, multiple system atrophy (MSA), frontotemporal lobular degeneration, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis, multiple sclerosis, Friedreichs ataxia, tardive dyskynesia, states of muscular dystrophy, Hereditary Cerebral Hemmorhage with Amyloidosis of the Dutch-Type, cerebral bleeding namely due to solitary cerebral amyloid angiopathy, ß-amyloid angiopathy and systemic amyloidosis and condition, neurotraumatic disease namely stroke, acute stroke, promotion of functional recovery post stroke, ischaemia, anxiety, epilepsy, brain injury, traumatic brain injury, brain diseases, head trauma, encephalitis, neural damage, crush injury, reperfusion injury, spinal cord injury, optic nerve injury, namely that caused by glaucoma, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, chronic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease, prion diseases as spongiform encephalopathy, Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinher disease, drug and alcohol addiction and mood disorders, namely depression, psychoses, schizophrenia and bipolar disorders, conditions associated with diabetes, namely non-insulin dependent diabetes mellitus and diabetes type II; Intermediate pharmaceutical and veterinary preparations sold as components of pharmaceutical and veterinary preparations for the treatment of the nervous system diseases and conditions, namely cognitive disorders, namely pre-senile dementia, senile dementia, cerebrovascular dementia, AIDS associated dementia, frontotemporal dementia, mild cognitive impairment and attention deficit disorder, neurogenerative dementing disease, and Alzheimer's disease, attention deficit symptoms associated with Alzheimers disease, diffuse Lewy body type Alzheimers disease, memory loss, Parkinson's disease, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex polyglutamine disease, Hungtington's disease, tauopathies as Pick's disease, multiple system atrophy (MSA), frontotemporal lobular degeneration, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis, multiple sclerosis, Friedreichs ataxia, tardive dyskynesia, states of muscular dystrophy, Hereditary Cerebral Hemmorhage with Amyloidosis of the Dutch-Type, cerebral bleeding namely due to solitary cerebral amyloid angiopathy, ß-amyloid angiopathy and systemic amyloidosis and condition, neurotraumatic disease namely stroke, acute stroke, promotion of functional recovery post stroke, ischaemia, anxiety, epilepsy, brain injury, traumatic brain injury, brain diseases, head trauma, encephalitis, neural damage, crush injury, reperfusion injury, spinal cord injury, optic nerve injury, namely that caused by glaucoma, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, chronic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease, prion diseases as spongiform encephalopathy, Creutzfeldt-Jakob disease oand Gerstmann-Straussler-Scheinher disease, drug and alcohol addiction and mood disorders, namely depression, psychoses, schizophrenia and bipolar disorders, conditions associated with diabetes, namely non-insulin dependent diabetes mellitus and diabetes type II. Class 005 Class 005 Pharmaceutical Products Business management assistance in relation to a company dedicated to the marketing of medical, pharmacy and parapharmacy products and articles of all kinds, generic, dietetic, perfumery, hygiene and oral hygiene specialities; business management and business administration; scientific and technological services and research in the medical and pharmaceutical fields; medical services, namely medical diagnostic laboratory testing, evaluation, research and screening services; medical services, namely the operation of a medical clinic; medical services, namely medical diagnostic and drug development services; providing of medical and pharmaceutical information on the Internet. ... Class 035 Advertising, Business & Retail Services Class 042 Computer & Software Services & Scientific Services Class 044 Medical, Beauty & Agricultural Services

ABANDONED SECTION 40(3)

on 14 Nov 2012

NOSCIRA

NOSCIRA S.A.

1415500 · 22 Oct 2008

001

Class 001

Chemical Products

1) Chemicals, reagents, compounds, and solvents for scientific and medical research; Pharmaceutical and veterinary preparations for the treatment of the nervous system diseases and conditions, namely cognitive disorders namely pre-senile dementia, senile dementia, cerebrovascular dementia, AIDS associated dementia, frontotemporal dementia, mild cognitive impairment and attention deficit disorder, neurogenerative dementing disease, namely Alzheimer's disease, attention deficit symptoms associated with Alzheimers disease, diffuse Lewy body type Alzheimers disease, memory loss, Parkinson's disease, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex polyglutamine disease, Hungtington's disease, tauopathies as Pick's disease, multiple system atrophy (MSA), frontotemporal lobular degeneration, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis, multiple sclerosis, Friedreichs ataxia, tardive dyskynesia, states of muscular dystrophy, Hereditary Cerebral Hemmorhage with Amyloidosis of the Dutch-Type, cerebral bleeding namely due to solitary cerebral amyloid angiopathy, ß-amyloid angiopathy and systemic amyloidosis and condition, neurotraumatic disease namely stroke, acute stroke, promotion of functional recovery post stroke, ischaemia, anxiety, epilepsy, brain injury, traumatic brain injury, brain diseases, head trauma, encephalitis, neural damage, crush injury, reperfusion injury, spinal cord injury, optic nerve injury, namely that caused by glaucoma, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, chronic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease, prion diseases as spongiform encephalopathy, Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinher disease, drug and alcohol addiction and mood disorders, namely depression, psychoses, schizophrenia and bipolar disorders, conditions associated with diabetes, namely non-insulin dependent diabetes mellitus and diabetes type II; Natural and synthetic bioactive preparations for application in the fields of human or animal medicine, namely pharmaceutical and veterinary preparations for the treatment of the nervous system diseases and conditions, namely cognitive disorders, namely pre-senile dementia, senile dementia, cerebrovascular dementia, AIDS associated dementia, frontotemporal dementia, mild cognitive impairment and attention deficit disorder, neurogenerative dementing disease, namely Alzheimer's disease, attention deficit symptoms associated with Alzheimers disease, diffuse Lewy body type Alzheimers disease, memory loss, Parkinson's disease, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex polyglutamine disease, Hungtington's disease, tauopathies as Pick's disease, multiple system atrophy (MSA), frontotemporal lobular degeneration, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis, multiple sclerosis, Friedreichs ataxia, tardive dyskynesia, states of muscular dystrophy, Hereditary Cerebral Hemmorhage with Amyloidosis of the Dutch-Type, cerebral bleeding namely due to solitary cerebral amyloid angiopathy, ß-amyloid angiopathy and systemic amyloidosis and condition, neurotraumatic disease namely stroke, acute stroke, promotion of functional recovery post stroke, ischaemia, anxiety, epilepsy, brain injury, traumatic brain injury, brain diseases, head trauma, encephalitis, neural damage, crush injury, reperfusion injury, spinal cord injury, optic nerve injury, namely that caused by glaucoma, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, chronic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease, prion diseases as spongiform encephalopathy, Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinher disease, drug and alcohol addiction and mood disorders, namely depression, psychoses, schizophrenia and bipolar disorders, conditions associated with diabetes, namely non-insulin dependent diabetes mellitus and diabetes type II; Intermediate pharmaceutical and veterinary preparations sold as components of pharmaceutical and veterinary preparations for the treatment of the nervous system diseases and conditions, namely cognitive disorders, namely pre-senile dementia, senile dementia, cerebrovascular dementia, AIDS associated dementia, frontotemporal dementia, mild cognitive impairment and attention deficit disorder, neurogenerative dementing disease, and Alzheimer's disease, attention deficit symptoms associated with Alzheimers disease, diffuse Lewy body type Alzheimers disease, memory loss, Parkinson's disease, subacute sclerosing panencephalitic parkinsonism, postencephalitic parkinsonism, pugilistic encephalitis, guam parkinsonism-dementia complex polyglutamine disease, Hungtington's disease, tauopathies as Pick's disease, multiple system atrophy (MSA), frontotemporal lobular degeneration, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), amyotrophic lateral sclerosis, multiple sclerosis, Friedreichs ataxia, tardive dyskynesia, states of muscular dystrophy, Hereditary Cerebral Hemmorhage with Amyloidosis of the Dutch-Type, cerebral bleeding namely due to solitary cerebral amyloid angiopathy, ß-amyloid angiopathy and systemic amyloidosis and condition, neurotraumatic disease namely stroke, acute stroke, promotion of functional recovery post stroke, ischaemia, anxiety, epilepsy, brain injury, traumatic brain injury, brain diseases, head trauma, encephalitis, neural damage, crush injury, reperfusion injury, spinal cord injury, optic nerve injury, namely that caused by glaucoma, central nervous system movement disorders, central nervous system infections, nociceptive and neuropathic pain, chronic pain, central nervous system inflammation, chronic inflammatory diseases, Down's syndrome, Lewy body disease, prion diseases as spongiform encephalopathy, Creutzfeldt-Jakob disease oand Gerstmann-Straussler-Scheinher disease, drug and alcohol addiction and mood disorders, namely depression, psychoses, schizophrenia and bipolar disorders, conditions associated with diabetes, namely non-insulin dependent diabetes mellitus and diabetes type II.

005

...

1) Chemicals, reagents, compounds, and solvents for scientific and med...

Owners

Noscira s.A. (1)

Categories

Class 1 (1)

Class 5 (1)

Class 35 (1)

Class 42 (1)

Class 44 (1)

Correspondents

Smart & biggar lp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo trademark

Trademark Name

Country Selected

Canada

$599 / 1 class + gov fee

United States

$99 / 1 class + gov fee

Canada

$599 / 1 class + gov fee

Mexico

$499 / 1 class + gov fee

European Union

$700 / 1 class + gov fee

China

$499 / 1 class + gov fee

South Korea

$699 / 1 class + gov fee

Japan

$799 / 1 class + gov fee

India

$99 / 1 class + gov fee

United Kingdom

$499 / 1 class + gov fee

Australia

$299 / 1 class + gov fee

Israel

$699 / 1 class + gov fee

United Arab Emirates

$699 / 1 class + gov fee

New Zealand

$699 / 1 class + gov fee

Brazil

$499 / 1 class + gov fee

Taiwan

$799 / 1 class + gov fee

Ukraine

$799 / 1 class + gov fee

Indonesia

$699 / 1 class + gov fee

South Africa

$499 / 1 class + gov fee

Singapore

$799 / 1 class + gov fee

Saudi Arabia

$799 / 1 class + gov fee

Afghanistan

$799 / 1 class + gov fee

Algeria

$799 / 1 class + gov fee

Argentina

$399 / 1 class + gov fee

Austria

$899 / 1 class + gov fee

Bahrain

$699 / 1 class + gov fee

Bangladesh

$599 / 1 class + gov fee

Benelux

$999 / 1 class + gov fee

Bhutan

$899 / 1 class + gov fee

Bolivia

$799 / 1 class + gov fee

Botswana

$1299 / 1 class + gov fee

British Virgin Islands

$1199 / 1 class + gov fee

Bulgaria

$799 / 1 class + gov fee

Cambodia

$799 / 1 class + gov fee

Chile

$499 / 1 class + gov fee

Colombia

$699 / 1 class + gov fee

Congo

$1199 / 1 class + gov fee

Costa Rica

$899 / 1 class + gov fee

Croatia

$899 / 1 class + gov fee

Cyprus

$999 / 1 class + gov fee

Czech Republic

$899 / 1 class + gov fee

Denmark

$799 / 1 class + gov fee

Dominican Republic

$899 / 1 class + gov fee

Ecuador

$799 / 1 class + gov fee

Egypt

$699 / 1 class + gov fee

El Salvador

$799 / 1 class + gov fee

Ethiopia

$1099 / 1 class + gov fee

France

$899 / 1 class + gov fee

Gaza

$799 / 1 class + gov fee

Germany

$899 / 1 class + gov fee

Greece

$799 / 1 class + gov fee

Guatemala

$899 / 1 class + gov fee

Haiti

$899 / 1 class + gov fee

Honduras

$899 / 1 class + gov fee

Hong Kong (SAR)

$899 / 1 class + gov fee

Hungary

$1099 / 1 class + gov fee

Iraq

$1499 / 1 class + gov fee

Italy

$899 / 1 class + gov fee

Jordan

$799 / 1 class + gov fee

Kazakhstan

$799 / 1 class + gov fee

Kenya

$899 / 1 class + gov fee

Kuwait

$799 / 1 class + gov fee

Laos

$699 / 1 class + gov fee

Lebanon

$999 / 1 class + gov fee

Lesotho

$1199 / 1 class + gov fee

Libya

$899 / 1 class + gov fee

Madrid Protocol (WIPO)

$1999 / 1 class + gov fee

Malawi

$1099 / 1 class + gov fee

Malaysia

$699 / 1 class + gov fee

Maldives

$999 / 1 class + gov fee

Morocco

$999 / 1 class + gov fee

Mozambique

$899 / 1 class + gov fee

Myanmar

$799 / 1 class + gov fee

Namibia

$799 / 1 class + gov fee

Nepal

$699 / 1 class + gov fee

Nicaragua

$899 / 1 class + gov fee

Norway

$899 / 1 class + gov fee

Oman

$1099 / 1 class + gov fee

Pakistan

$799 / 1 class + gov fee

Panama

$899 / 1 class + gov fee

Paraguay

$899 / 1 class + gov fee

Peru

$799 / 1 class + gov fee

Philippines

$899 / 1 class + gov fee

Poland

$499 / 1 class + gov fee

Portugal

$899 / 1 class + gov fee

Puerto Rico

$899 / 1 class + gov fee

Qatar

$799 / 1 class + gov fee

Romania

$899 / 1 class + gov fee

Serbia

$899 / 1 class + gov fee

Slovakia

$899 / 1 class + gov fee

Spain

$899 / 1 class + gov fee

Sri Lanka

$699 / 1 class + gov fee

Swaziland

$1299 / 1 class + gov fee

Sweden

$799 / 1 class + gov fee

Switzerland

$899 / 1 class + gov fee

Thailand

$799 / 1 class + gov fee

Tunisia

$899 / 1 class + gov fee

Turkey

$799 / 1 class + gov fee

Uganda

$699 / 1 class + gov fee

United Republic of Tanzania

$699 / 1 class + gov fee

Uruguay

$799 / 1 class + gov fee

Venezuela

$899 / 1 class + gov fee

Vietnam

$799 / 1 class + gov fee

West Bank, Palestine

$799 / 1 class + gov fee

Yemen

$1699 / 1 class + gov fee

Albania

$899 / 1 class + gov fee

Andorra

$899 / 1 class + gov fee

Angola

$1299 / 1 class + gov fee

Antigua and Barbuda

$1299 / 1 class + gov fee

Armenia

$799 / 1 class + gov fee

Azerbaijan

$799 / 1 class + gov fee

Bahamas

$1399 / 1 class + gov fee

Barbados

$1299 / 1 class + gov fee

Belgium

$999 / 1 class + gov fee

Belize

$1299 / 1 class + gov fee

Benin

$799 / 1 class + gov fee

Bosnia and Herzegovina

$999 / 1 class + gov fee

Brunei

$1299 / 1 class + gov fee

Burkina Faso

$799 / 1 class + gov fee

Burundi

$1199 / 1 class + gov fee

Cabo Verde

$899 / 1 class + gov fee

Cameroon

$799 / 1 class + gov fee

Central African Republic (CAR)

$799 / 1 class + gov fee

Chad

$799 / 1 class + gov fee

Comoros

$799 / 1 class + gov fee

Cote d'Ivoire

$799 / 1 class + gov fee

Czechia

$999 / 1 class + gov fee

Djibouti

$1199 / 1 class + gov fee

Dominica

$1299 / 1 class + gov fee

Equatorial Guinea

$799 / 1 class + gov fee

Eritrea

$999 / 1 class + gov fee

Estonia

$1299 / 1 class + gov fee

Eswatini

$1299 / 1 class + gov fee

Fiji

$899 / 1 class + gov fee

Finland

$699 / 1 class + gov fee

Gabon

$799 / 1 class + gov fee

Gambia

$899 / 1 class + gov fee

Georgia

$799 / 1 class + gov fee

Ghana

$999 / 1 class + gov fee

Grenada

$1299 / 1 class + gov fee

Guinea

$799 / 1 class + gov fee

Guinea-Bissau

$799 / 1 class + gov fee

Guyana

$1299 / 1 class + gov fee

Iceland

$1299 / 1 class + gov fee

Ireland

$899 / 1 class + gov fee

Jamaica

$1199 / 1 class + gov fee

Kiribati

$999 / 1 class + gov fee

Kosovo

$899 / 1 class + gov fee

Kyrgyzstan

$899 / 1 class + gov fee

Latvia

$699 / 1 class + gov fee

Liberia

$999 / 1 class + gov fee

Liechtenstein

$999 / 1 class + gov fee

Lithuania

$699 / 1 class + gov fee

Luxembourg

$999 / 1 class + gov fee

Madagascar

$999 / 1 class + gov fee

Mali

$799 / 1 class + gov fee

Malta

$599 / 1 class + gov fee

Marshall Islands

$999 / 1 class + gov fee

Mauritania

$799 / 1 class + gov fee

Mauritius

$899 / 1 class + gov fee

Micronesia

$999 / 1 class + gov fee

Moldova

$999 / 1 class + gov fee

Monaco

$1399 / 1 class + gov fee

Mongolia

$599 / 1 class + gov fee

Montenegro

$899 / 1 class + gov fee

Nauru

$999 / 1 class + gov fee

Netherlands

$999 / 1 class + gov fee

Niger

$799 / 1 class + gov fee

Nigeria

$399 / 1 class + gov fee

North Macedonia

$899 / 1 class + gov fee

Palau

$999 / 1 class + gov fee

Palestine

$999 / 1 class + gov fee

Papua New Guinea

$799 / 1 class + gov fee

Rwanda

$999 / 1 class + gov fee

Saint Kitts and Nevis

$1299 / 1 class + gov fee

Saint Lucia

$1299 / 1 class + gov fee

Saint Vincent and the Grenadines

$1299 / 1 class + gov fee

Samoa

$1199 / 1 class + gov fee

San Marino

$999 / 1 class + gov fee

Sao Tome and Principe

$999 / 1 class + gov fee

Senegal

$799 / 1 class + gov fee

Seychelles

$999 / 1 class + gov fee

Sierra Leone

$999 / 1 class + gov fee

Slovenia

$899 / 1 class + gov fee

Solomon Islands

$999 / 1 class + gov fee

Somalia

$999 / 1 class + gov fee

South Sudan

$999 / 1 class + gov fee

Suriname

$1599 / 1 class + gov fee

Tajikistan

$799 / 1 class + gov fee

Tanzania

$699 / 1 class + gov fee

Timor-Leste

$999 / 1 class + gov fee

Togo

$799 / 1 class + gov fee

Tonga

$1299 / 1 class + gov fee

Trinidad and Tobago

$1399 / 1 class + gov fee

Turkmenistan

$799 / 1 class + gov fee

Tuvalu

$999 / 1 class + gov fee

Uzbekistan

$699 / 1 class + gov fee

Vanuatu

$1199 / 1 class + gov fee

Zambia

$899 / 1 class + gov fee

Zimbabwe

$899 / 1 class + gov fee

OAPI

$899 / 1 class + gov fee

ARIPO

$999 / 1 class + gov fee

End of search results

Page 1 of 1